Rentabilitas dodolan miturut bathi resik: exicuretx.com (XCUR)

exicuretx.com (XCUR) - logo korporat

Exicure, Inc. (XCUR) develops scalable gene therapy methods where low synthesis costs expand the product pipeline. The net margin as a percentage of revenue illustrates current profitability, while the 0.00 mark indicates the level of competitiveness. Business stability relies on strategic grants regardless of GDP; however, significant risks of delisting and strategic pivots necessitate caution.

Exicure Inc. (XCUR) - Rentabilitas dodolan miturut bathi resik saka 04.07.2022 nganti 19.11.2026

exicuretx.com (XCUR) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analisis perusahaan:Exicure, Inc.
Produk asil prodhuksi Exicure, Inc.

Exicure, Inc. operates in the high-risk biotechnology sector. An analysis of the net profit margin allows for an assessment of the efficiency with which sales are converted into net income after all expenses are deducted. This metric measures the business's ability to generate real cash flow amidst a shortage of working capital. For a company in an asset restructuring phase, a negative trend in this indicator signals a critical increase in operating expenses. A stable recovery of this metric will serve as a key signal for the reduction of liquidity risks.

Pesaing wigati

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|SRPT - Margin dodolan resik|TWST (Twist Bio) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik TXG|Rentabilitas dodolan miturut bathi resik NTLA|Stoke Therapeutics Inc (STOK) - Margin dodolan perusahaan|Margin dodolan resik BLFS|Margin resik WVE (Wave Life Sciences Corp)|Margin resik Maze Therapeutics MAZE|Tingkat bathi resik SION|PRME - Margin resik|Margin dodolan perusahaan Taysha TSHA|QURE: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Margin dodolan resik|solidbio.com (SLDB) - Margin dodolan perusahaan|Margin resik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Rentabilitas dodolan resik|Benitec Biopharma - Rentabilitas dodolan miturut bathi resik|DSGN: Rentabilitas dodolan resik|RCKT: Rentabilitas dodolan miturut bathi resik|FDMT - Margin dodolan resik|LXEO: Margin dodolan resik|Korro Bio Inc. - Tingkat bathi resik|EDIT (editasmedicine.com) - Margin dodolan resik|Margin resik SLN|Margin resik ProQR Therapeutics NV (PRQR)|Codexis - Rentabilitas dodolan resik|Margin resik Sangamo SGMO|NAUT: Rentabilitas dodolan resik|MGX: Rentabilitas dodolan miturut bathi resik|Margin resik Precision BioSciences|GBIO (generationbio.com) - Rentabilitas dodolan miturut bathi resik|Margin resik boundlessbio.com (BOLD)|Margin resik Imunon|Phio Pharmaceuticals - Margin bathi resik|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX